The pharmaceutical giant reported that Chief Executive Officer Pascal Soriot and Chief Financial Officer Aradhana Sarin received shares as part of the AstraZeneca (NASDAQ:AZN) Deferred Bonus Plan ...

The lawsuit, which AstraZeneca detailed in its annual report on Tuesday, alleges that the company, its chief executive Pascal Soriot and chief financial officer Aradhana Sarin made “materially ...

The pharmaceutical giant reported that Chief Executive Officer Pascal Soriot and Chief Financial Officer Aradhana Sarin received shares as part of the AstraZeneca (NASDAQ:AZN) Deferred Bonus Plan ...

In another development, AstraZeneca disclosed that top executives, including CEO Pascal Soriot and CFO Aradhana Sarin, have acquired shares following the vesting of a deferred bonus plan.

CFO Aradhana Sarin noted that full-year total revenue grew 21%, exceeding guidance, while product sales climbed 19%, driven by strong demand across regions and therapy areas. She emphasized that ...